Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Panbela Therapeutics Third Quarter 2024 Earnings Call.
Panbela Therapeutics Inc. (PBLA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ikarian Capital Neil Shahrestani | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 4,444 | Officer, Director | 7,868 | 2023-01-30 | Filing | |
| $0.00 | 4,444 | Officer | 17,880 | 2023-01-30 | Filing | |
| $0.00 | 165,000 | Large Shareholder, Director | 369,576 | 2022-10-04 | Filing | |
| $0.00 | 200,000 | Large Shareholder, Director | 482,654 | 2022-10-04 | Filing | |
| $0.00 | 33,000 | Director | 294,931 | 2022-10-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.71 | 72,874 | Large Shareholder | 397,954 | 2023-11-08 | Filing | |
| $3.00 | 343,411 | Large Shareholder | 212,127 | 2019-08-16 | Filing | |
| $0.00 | 47,025 | Large Shareholder | 0 | 2018-08-15 | Filing | |
| $1.43 | 7,000 | Large Shareholder, Director | 2,826,548 | 2016-11-14 | Filing | |
| $0.00 | 216,705 | 74,825 | 2015-09-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Panbela Therapeutics Second Quarter 2024 Earnings Call. At this time, all participants have been placed on a listen-only mode.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Panbela Therapeutics First Quarter 2024 Earnings Call. [Operator Instructions].
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2023 Earnings Call Transcript
Operator: Greetings. Welcome to Panbela Therapeutics Fourth Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Panbela Therapeutics Third Quarter 2023 Earnings Call. [Operator Instructions] Please note this conference is being recorded.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Panbela Therapeutics Second Quarter 2023 Earnings Call. [Operator Instructions] Please note this conference is being recorded.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q1 2023 Earnings Call Transcript
James Carbonara: Thank you, operator. With me on the call are Jennifer Simpson, Chief Executive Officer; and to Sue Horvath, Chief Financial Officer. Before I turn the call over to Dr.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2022 Earnings Call Transcript
Operator: Good day, everyone. And welcome to the Panbela Therapeutics Fourth Quarter 2022 Earnings Call.
10 Pump and Dump Stocks Hedge Funds Like
The influx of retail investors on the stock market in recent months and the rise of social media speculation around meme stocks has given strong momentum to pump and dump schemes.